GCKR rs1260326: What Your Genotype Means
The rs1260326 variant is a common genetic change in the GCKR gene that results in a protein substitution known as P446L. This variant is widely studied for its statistical association with levels of fasting blood glucose and triglycerides in the general population.
What each genotype means
Baseline metabolic profile
This genotype represents the common, non-variant form of the GCKR gene at this position. Research indicates that individuals with this genotype typically exhibit baseline levels of fasting glucose and triglycerides compared to those carrying the T allele.
This is the most common genotype in many global populations, though frequency varies significantly by ancestry.
Altered metabolic trait association
Carrying one copy of the T allele (often referred to as the P446L variant) is associated with variations in fasting plasma glucose and triglyceride levels. Studies suggest this variant may influence how the liver regulates glucose, potentially leading to lower fasting blood glucose but higher triglyceride levels in some individuals.
The T allele is common, with a global minor allele frequency of approximately 0.3, meaning this heterozygous genotype is found in a large portion of the population.
Increased metabolic trait association
Carrying two copies of the T allele is associated with a more pronounced effect on metabolic markers, including potentially higher triglyceride levels and lower fasting glucose. Because this variant is linked to complex metabolic traits, you should discuss any concerns regarding your lipid or glucose levels with your clinician or healthcare provider.
This homozygous genotype is less common than the heterozygous form but is still frequently observed across diverse populations.
Understanding the rs1260326 Variant
The rs1260326 variant is a single nucleotide polymorphism (SNP) located within the GCKR gene on chromosome 2. This specific change involves a transition from a cytosine to a thymine, which leads to a non-synonymous amino acid substitution where proline is replaced by leucine at position 446 of the glucokinase regulatory protein (GKRP). Because this change alters the protein's structure, it has been the subject of extensive research to determine how it influences metabolic processes. The variant is considered common, meaning it is found frequently across many different human populations. Scientists often use this SNP as a marker in genome-wide association studies to better understand the genetic architecture of metabolic traits, such as how the body processes sugars and fats.
The Role of the GCKR Gene
The GCKR gene provides instructions for making the glucokinase regulatory protein (GKRP). This protein acts as a key regulator of glucokinase (GCK), an enzyme that plays a central role in glucose metabolism within the liver. Under normal conditions, GKRP binds to glucokinase and sequesters it in the cell nucleus, effectively inhibiting its activity. When blood glucose levels rise, the interaction between GKRP and glucokinase changes, allowing the enzyme to move into the cytoplasm where it can begin processing glucose. The P446L substitution caused by the rs1260326 variant is thought to impair this inhibitory function. By reducing the ability of GKRP to hold glucokinase in the nucleus, the variant may lead to increased glucokinase activity, which influences how the liver takes up glucose and subsequently affects the production of triglycerides.
Research Associations and Evidence
Research has consistently identified a statistical association between the rs1260326 variant and metabolic biomarkers. Specifically, the minor allele is frequently associated with lower fasting plasma glucose levels and higher fasting triglyceride levels. While these associations are robust across many studies, the evidence is considered limited in terms of clinical diagnostic utility. It is important to note that these findings represent population-level trends rather than individual health predictions. Factors such as diet, lifestyle, and other genetic influences also play significant roles in determining an individual's metabolic profile. For instance, some studies have suggested that adherence to specific dietary patterns, such as the Mediterranean diet, may modulate the impact of this variant on triglyceride concentrations. Because these associations are complex and influenced by many variables, this information should not be used to diagnose or manage health conditions.
What This Information Means for You
Learning about your genotype for rs1260326 provides insight into a common genetic variation, but it does not provide a medical diagnosis. Because this variant is associated with metabolic traits that are also heavily influenced by environment and lifestyle, your genotype is only one piece of a much larger puzzle. You cannot use this information to determine your risk for specific diseases or to guide medical treatment. If you have concerns about your blood glucose, triglyceride levels, or overall metabolic health, it is essential to consult with a healthcare professional. They can interpret your clinical lab results in the context of your full medical history and provide appropriate guidance. Never make changes to your diet, exercise, or medication regimen based on genetic test results without first discussing them with your clinician or pharmacist.
How common is this variant?
The rs1260326 variant is common, with a global minor allele frequency of approximately 0.30 to 0.35, meaning that a significant portion of the population carries at least one copy of the variant.
Frequently asked questions
Is rs1260326 a cause of diabetes?
No, rs1260326 is not a direct cause of diabetes. While it is associated with variations in fasting glucose levels, it is a common genetic variant that contributes to normal human diversity rather than being a diagnostic marker for disease.
Should I change my diet based on my GCKR genotype?
You should not change your diet based on this genotype alone. Any dietary changes should be discussed with a registered dietitian or your doctor, who can consider your overall health, blood work, and personal goals.
Does this variant affect my cholesterol levels?
Some research has explored the relationship between GCKR variants and lipid profiles, including cholesterol and triglycerides. However, these associations are complex and influenced by many other factors, so you should rely on clinical blood tests for an accurate assessment of your cholesterol.
Can I use this information to predict my future health?
Genetic variants like rs1260326 provide information about biological tendencies, not future health outcomes. Many factors, including your environment and lifestyle, are much more influential in determining your long-term health than a single genetic variant.
Sources & further reading
Educational information only, last refreshed 10/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1260326?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GCKR
A significant SNP identified through fine-mapping that demonstrates a consistent effect on triglyceride levels across different ancestral populations.
A well-replicated regulatory/intronic variant within GCKR strongly associated with variation in fasting serum triglycerides, glucose levels, and lipid metabolism.
This variant in the GCKR gene is strongly linked to altered glucokinase regulation, influencing fasting blood triglyceride and glucose levels.
This variant is associated with variations in fasting glucose and lipid levels, commonly studied in metabolic GWAS.
This variant in the glucokinase regulator (GCKR) locus is significantly associated with altered fasting plasma glucose, serum triglyceride levels, and hepatic fat accumulation.